Regulators are supposed to abide by the “bargain” that society has made with them: Civil servants are granted lifetime tenure and are protected from political pressure and retaliation, in return for ...
Hefei Tianhui Incubator of Technologies Co. Ltd. (HTIT)’s NDA for recombinant human insulin capsule ORMD-0801 for type 2 diabetes is under review by the NMPA and, if approved, is expected to be the ...
Preliminary results from a phase II study of ARQ 197 in patients with microphthalmia transcription factor family (MiT)-associated tumors ...
Researchers have created a slow-release ‘smart’ insulin that responds to blood glucose levels to provide week-long control with virtually no incidents of low blood sugar. Tested in mice and minipigs, ...
Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues found that an investigational protein replacement – recombinant human ...
A major challenge for people who have a form of diabetes is the need to regulate the glucose levels in their body. Normally this is where the body’s insulin-producing cells would respond to glucose ...
Biopharmaceuticals, also known as biologics, are a class of medicines produced using living systems such as microorganisms, plant or animal cells, or recombinant DNA technology. Unlike traditional ...
The U.S. Consumer Financial Protection Bureau issued a list on Friday of nearly 70 policy and regulatory guidance documents stretching back more than a decade that the agency plans to rescind.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results